Skip to main content
. 2011 Aug;1812(8):836–841. doi: 10.1016/j.bbadis.2011.03.009

Table 1.

Proteomics quotients for the identification of potential FXR targets along with corresponding mRNA quotients.

3.

Gray shading, FXR targets showing a difference at the protein level but not at the mRNA level after FXR ligand treatment. ND, mRNA levels below background level in the microarray analysis, i.e. not detectable.